• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical response to subcutaneous immunotherapy at 3 years in allergic rhinitis patients is predicted by short-term treatment effectiveness.

作者信息

Liu Dong, Li Jingyun, Gao Yunbo, Cao Feifei, Xiong Wei, Wang Chengshuo, Zhang Yuan, Zhang Luo

机构信息

Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

出版信息

Clin Transl Allergy. 2023 Feb;13(2):e12223. doi: 10.1002/clt2.12223.

DOI:10.1002/clt2.12223
PMID:36825515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9911623/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc0/9911623/9d652fa69c31/CLT2-13-e12223-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc0/9911623/9d652fa69c31/CLT2-13-e12223-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc0/9911623/9d652fa69c31/CLT2-13-e12223-g001.jpg

相似文献

1
Clinical response to subcutaneous immunotherapy at 3 years in allergic rhinitis patients is predicted by short-term treatment effectiveness.短期治疗效果可预测变应性鼻炎患者皮下免疫治疗3年时的临床反应。
Clin Transl Allergy. 2023 Feb;13(2):e12223. doi: 10.1002/clt2.12223.
2
[Influence of different levels of skin pricking test on the short-term efficacy of subcutaneous immunotherapy in allergic rhinitis].[不同程度皮肤点刺试验对变应性鼻炎皮下免疫治疗短期疗效的影响]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Jan 20;32(2):102-105. doi: 10.13201/j.issn.1001-1781.2018.02.006.
3
Long-term efficacy of standardised specific subcutaneous immunotherapy in children with persistent allergic rhinitis due to multiple allergens including house dust mites.标准化特异性皮下免疫疗法对因包括屋尘螨在内的多种过敏原引起的持续性变应性鼻炎儿童的长期疗效。
J Laryngol Otol. 2018 Mar;132(3):230-235. doi: 10.1017/S0022215117002547. Epub 2018 Jan 28.
4
Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis.鼻细胞学检查可预测皮下免疫疗法治疗间歇性变应性鼻炎的临床疗效。
Postepy Dermatol Alergol. 2022 Dec;39(6):1110-1115. doi: 10.5114/ada.2022.117978. Epub 2022 Jul 10.
5
Subcutaneous immunotherapy for allergic rhinitis: an evidence based review of the recent literature with recommendations.变应性鼻炎皮下免疫治疗：基于证据的近期文献综述及推荐意见
Int Forum Allergy Rhinol. 2013 Jul;3(7):519-31. doi: 10.1002/alr.21141. Epub 2013 Jan 11.
6
Effectiveness and adverse reactions to subcutaneous immunotherapy in children with allergic rhinitis/asthma.皮下免疫疗法对过敏性鼻炎/哮喘患儿的疗效及不良反应
Int J Pediatr Otorhinolaryngol. 2022 Nov;162:111292. doi: 10.1016/j.ijporl.2022.111292. Epub 2022 Aug 19.
7
Long-term effects of allergen-specific subcutaneous immunotherapy for house dust mite induced allergic rhinitis.屋尘螨诱导的变应性鼻炎的变应原特异性皮下免疫疗法的长期疗效
J Laryngol Otol. 2017 Nov;131(11):997-1001. doi: 10.1017/S0022215117002110. Epub 2017 Oct 17.
8
Efficacy of subcutaneous house dust mite immunotherapy in patients with moderate to severe allergic rhinitis.皮下屋尘螨变应原免疫治疗中重度变应性鼻炎的疗效。
Immunotherapy. 2022 Jun;14(9):683-694. doi: 10.2217/imt-2021-0353. Epub 2022 Apr 25.
9
10
[Evaluation of long-term effect for house dust mite subcutaneous immunotherapy for patients with allergic rhinitis].[尘螨皮下免疫疗法对变应性鼻炎患者的长期疗效评估]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Aug;50(8):632-5.

引用本文的文献

1
[Value of allergen nasal provocation test in assessment of the efficacy of house dust mites specific immunotherapy].[变应原鼻激发试验在评估屋尘螨特异性免疫治疗疗效中的价值]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Jun;37(6):428-433;441. doi: 10.13201/j.issn.2096-7993.2023.06.005.

本文引用的文献

1
Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy.协调的 IgG2 和 IgE 应答作为变应原免疫治疗疗效的标志物。
Allergy. 2022 Apr;77(4):1263-1273. doi: 10.1111/all.15107. Epub 2021 Oct 6.
2
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.EAACI 变应原免疫治疗指南：过敏性鼻结膜炎。
Allergy. 2018 Apr;73(4):765-798. doi: 10.1111/all.13317. Epub 2017 Oct 30.
3
Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.变应性鼻炎结膜炎的变应原免疫治疗：系统评价和荟萃分析。
Allergy. 2017 Nov;72(11):1597-1631. doi: 10.1111/all.13201. Epub 2017 Jul 14.
4
Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: A Systematic Review and Meta-analysis.舌下免疫治疗草花粉变应原片剂治疗季节性过敏性鼻结膜炎的疗效：系统评价和荟萃分析。
JAMA Intern Med. 2015 Aug;175(8):1301-9. doi: 10.1001/jamainternmed.2015.2840.
5
Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison.皮下和舌下免疫疗法治疗季节性变应性鼻炎：系统评价和间接比较。
J Allergy Clin Immunol. 2013 May;131(5):1361-6. doi: 10.1016/j.jaci.2013.02.013. Epub 2013 Apr 1.
6
A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy.调节性树突状细胞特征与变应原特异性舌下免疫治疗的临床疗效相关。
J Allergy Clin Immunol. 2012 Apr;129(4):1020-30. doi: 10.1016/j.jaci.2012.02.014.
7
Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy.评估血清特异性IgE/总IgE比值在预测变应原特异性免疫治疗临床反应中的作用。
J Allergy Clin Immunol. 2009 May;123(5):1103-10, 1110.e1-4. doi: 10.1016/j.jaci.2009.02.012. Epub 2009 Apr 7.